Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.1800
+0.0150 (9.09%)
Sep 15, 2025, 4:20 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 139.62 million as of September 15, 2025. Its market cap has increased by 607.52% in one year.
Market Cap
139.62M
Enterprise Value
147.29M
Revenue
18.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
Market Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 139.62M, a decrease of -29.02%. That is a compound annual growth rate of -7.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 139.62M | 432.93% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | 196.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 100.67B |
| Pro Medicus | 30.74B |
| Cochlear | 19.61B |
| Sonic Healthcare | 11.13B |
| Ramsay Health Care | 7.72B |
| Ansell | 4.89B |
| Telix Pharmaceuticals | 4.63B |
| Mesoblast | 2.97B |